Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what support his Department is providing for (a) research on and (b) trials of oral vaccines offering immunity to covid-19.

Through a joint rolling research call for COVID-19 research between the National Institute for Health Research and UK Research and Innovation, funding of over £500,000 has been committed to a study looking at the safety and immunogenicity of two candidate COVID-19 vaccines administered to the respiratory tract in aerosol form, with an expected end date in August 2021.

In addition, Innovate UK, have been managing the delivery of £75 million of the £110 million Department-funded UK Vaccine Network programme. Nine Departmental projects within this portfolio were repurposed to identify other COVID-19 vaccines solutions. Also, two Innovate UK grants worth over £2.2 million in total, were awarded to Stabilitech, now known as IosBio, to assess its COVD-19 vaccine candidate that has an oral capsule delivery system in animal efficacy studies. This technology is now being tested in participants in clinical trials in South Africa and the United States.